Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Dowlais Group (DWL) by Jefferies
- Buy Norcros (NXR) by Berenberg
- Buy Volex (VLX) by Tom Winnifrith in ShareProphets
- Buy Volex (VLX) by Steve Moore in ShareProphets
- Buy Origin Enterprises (CDI) (OGN) by Shore Capital
- Buy Victorian Plumbing Group (VIC) by Shore Capital
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
Advanced Oncotherapy (AVO) Share Price
Health Care Sector
NOTE: This is based on 89 open tips for Advanced Oncotherapy (AVO)
| Latest Bid : 1.75p | Latest Ask : 2.10p |
| High Today : 2.10p | Low Today : 1.84p |
| This Years High : 25.00p | This Years Low : 1.84p |
| Volume : 827,834 | MKT Cap : £10.41M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
01/07/2016 – Stock Consolidation 25.000:1.000
Advanced Oncotherapy (AVO) Overview
Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.Advanced Oncotherapy (AVO) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-06-25 10:40:00 25/06/2023 | 19.12% |
| Sell | Nigel Somerville | Premium Only | 2023-06-01 11:50:00 01/06/2023 | 61.50% |
| Sell | Nigel Somerville | Premium Only | 2023-05-16 08:15:00 16/05/2023 | 74.33% |
| Sell | Nigel Somerville | Premium Only | 2023-02-11 10:00:00 11/02/2023 | 74.33% |
| Sell | Tom Winnifrith | Premium Only | 2023-01-27 08:30:00 27/01/2023 | 80.75% |
Advanced Oncotherapy (AVO) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.75p | Latest Ask : 2.10p |
| High Today : 2.10p | Low Today : 1.84p |
| This Years High : 25.00p | This Years Low : 1.84p |
| Volume : 827,834 | MKT Cap : £10.41M |
Advanced Oncotherapy Overview
Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Advanced Oncotherapy Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-06-25 10:40:00 25/06/2023 | 19.12% |
| Sell | Nigel Somerville | Premium Only | 2023-06-01 11:50:00 01/06/2023 | 61.50% |
| Sell | Nigel Somerville | Premium Only | 2023-05-16 08:15:00 16/05/2023 | 74.33% |
| Sell | Nigel Somerville | Premium Only | 2023-02-11 10:00:00 11/02/2023 | 74.33% |
| Sell | Tom Winnifrith | Premium Only | 2023-01-27 08:30:00 27/01/2023 | 80.75% |
Stock Splits and Consolidations
01/07/2016 – Stock Consolidation 25.000:1.000